Diagnostics Devices Drugs & Therapy Data

Israeli Startups and German SMEs – Medical Technology

 

The digital health sector is prospering in Israel. With over 550 innovative companies, technology hubs, R&D centers, incubators and multiantional corporations in this space, the vibrant Israeli digital health ecosystem has more than doubled in size since 2011. Within this ecosystem, approximately 40% of digital health companies utilize Artificial Intelligence in thei solutions.

This virtual event gives German SMEs a short overview of the Israeli digital health sector. Furthermore, four Startups will present their innovations, products and services to the audience. The Subsectors minimal invasive surgery, remote monitoring and digital therapeutics are mainly represented in the pitches of the Startups.

All of the startups‘ innovations are related to artificial intelligence and operate in the following areas:

  • micro cameras and supplementary technology (minimal invasive surgery)
  • Diabetis treatment by Engineered Micro Pancreas (EMP)
  • contact-free monitoring of human vital signs
  • biotechnology for precision medicine technology

IHK Reutlingen and IHK Stuttgart

Charme Rykower, Senior Executive, Innovations- & Cooperationscout Baden Württemberg, AHK Israel

Yoav Fisher, Head of Technological Innovation and Digital Health, HealthIL

Speaker:
David Messer, VP Business Development

ScoutCam develops and manufactures customized visual solutions in the form of highly resistant micro-cameras and supplementary technologies. The cameras are as small as 1 millimeter in diameter including illumination.

The company’s high-resolution technology has been authenticated by customers such as NASA in strict environmental conditions including extreme temperatures, vibrations, and radiation.

ScoutCam is a wholly owned subsidiary of Medigus.

Speaker:
Shay Hershcovich, Co-Founder and Marketing Manager

Betalin Therapeutics seeks to eliminate the need for insulin injections and glucose testing in diabetes patients with its proprietary transplanted Engineered Micro Pancreas (EMP). The EMP technology helps create connective tissue that enables the body’s beta cells to function properly and produce adequate and functional insulin.

Betalin Therapeutics licensed the novel EMP technology developed at the Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.

Sonovia produces a sono-fishing technology, which is scientifically proven to provide active protection against viruses, bacteria and funghi at over 99% efficacy.

Speaker:
Michael Hirsh, Director for Business Development

Neteera is focused on bridging the gap between the analog and digital worlds by enabling seamless, continuous, and contact-free monitoring of human vital signs.

Neteera’s micro-radar-on-chip and proprietary algorithms can detect microscopic skin motions through clothing. This takes place at a very high frequency, allowing for noninvasive, seamless, continuous monitoring of human vital signs such as heart and respiration rates, heart rate variability, inhale–exhale ratio, and tidal volume, and many more features under development.

The company’s technology is non-vision-based (camera-free) and the company ensures that all information obtained is completely anonymized, providing ultimate privacy. Collected data is stored in the Neteera HIPAA- and GDPR-compliant cloud for further analysis, EMR/EHR integration, and future decision support mechanisms.

Neteera’s technology is is clinically validated with an FDA 510(k) Class I exemption and a 510(k) Class II planned in 2021. The company is globally recognized as disruptive and innovative and was ranked 9th out of 1,350 companies in CNBC’s 2020 Disruptor 50 list.

Speaker:
Roni Zidon, Vice President of Business Development

AceTech develops precision medicine technology for the prediction of adverse effects and prescription products for their prevention and management. A privately owned, vertically integrated (from plantation to final product) biotechnology company, AceTech executes transitional research to create precision medicine solutions and develop biopharmaceutical Rx and OTC products targeting the skin and dental care markets.

The company uses biomedical sensors, artificial intelligence, big data algorithms, and microbiome profiling to collect, connect, and analyze big data measurements and create an individual skin signature which is then translated into a personalized prescription and recommendations. Its prescription products are designed to provide a four-R solution: The Right patient, with the Right product, at the Right dose, and on the Right schedule for its prevention and management.

Q&A Session

Termin

Datum:
13.07.2021

Zeit:
15:00–16:15 Uhr

Kosten:
Kostenfrei

Veranstalter

IHK Reutlingen

Ort

Online-Veranstaltung / Webinar

Kontakt

IHK Reutlingen
Hindenburgstr. 54, 72762 Reutlingen
Tel. 07121 201 – 244